JP2024521774A - Rasの阻害方法 - Google Patents

Rasの阻害方法 Download PDF

Info

Publication number
JP2024521774A
JP2024521774A JP2023572737A JP2023572737A JP2024521774A JP 2024521774 A JP2024521774 A JP 2024521774A JP 2023572737 A JP2023572737 A JP 2023572737A JP 2023572737 A JP2023572737 A JP 2023572737A JP 2024521774 A JP2024521774 A JP 2024521774A
Authority
JP
Japan
Prior art keywords
optionally substituted
membered
alkyl
hydrogen
ras
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521774A5 (cg-RX-API-DMAC7.html
Inventor
シーマン、カイル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revolution Medicines Inc
Original Assignee
Revolution Medicines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revolution Medicines Inc filed Critical Revolution Medicines Inc
Publication of JP2024521774A publication Critical patent/JP2024521774A/ja
Publication of JP2024521774A5 publication Critical patent/JP2024521774A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2023572737A 2021-05-25 2022-05-25 Rasの阻害方法 Pending JP2024521774A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163192837P 2021-05-25 2021-05-25
US63/192,837 2021-05-25
PCT/US2022/030823 WO2022251292A1 (en) 2021-05-25 2022-05-25 Methods for inhibiting ras

Publications (2)

Publication Number Publication Date
JP2024521774A true JP2024521774A (ja) 2024-06-04
JP2024521774A5 JP2024521774A5 (cg-RX-API-DMAC7.html) 2025-06-02

Family

ID=82115695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572737A Pending JP2024521774A (ja) 2021-05-25 2022-05-25 Rasの阻害方法

Country Status (11)

Country Link
US (1) US20240277796A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346898A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024521774A (cg-RX-API-DMAC7.html)
KR (1) KR20240026526A (cg-RX-API-DMAC7.html)
CN (2) CN117715658A (cg-RX-API-DMAC7.html)
AU (1) AU2022281343A1 (cg-RX-API-DMAC7.html)
CA (1) CA3219533A1 (cg-RX-API-DMAC7.html)
IL (1) IL308771A (cg-RX-API-DMAC7.html)
MX (1) MX2023013912A (cg-RX-API-DMAC7.html)
TW (1) TW202313631A (cg-RX-API-DMAC7.html)
WO (1) WO2022251292A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
IL301298A (en) 2020-09-15 2023-05-01 Revolution Medicines Inc Indole derivatives as RAS inhibitors in cancer therapy
IL308195A (en) 2021-05-05 2024-01-01 Revolution Medicines Inc RAS inhibitors for cancer treatment
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
EP4463231A1 (en) * 2022-01-10 2024-11-20 Revolution Medicines, Inc. Ras inhibitors
WO2023232776A1 (en) * 2022-06-01 2023-12-07 F. Hoffmann-La Roche Ag Haloindole macrocyclic compounds for the treatment of cancer
EP4596552A1 (en) 2022-09-29 2025-08-06 Guangzhou Joyo Pharmatech Co., Ltd Macrocyclic derivative and use thereof
PE20252395A1 (es) 2023-02-14 2025-10-10 Hoffmann La Roche Compuestos triciclicos para el tratamiento de cancer
CN121487738A (zh) * 2023-03-30 2026-02-06 锐新医药公司 诱导ras gtp水解的组合物和其用途
TW202446387A (zh) * 2023-04-06 2024-12-01 瑞士商赫孚孟拉羅股份公司 用於治療癌症之三環化合物
KR20260019479A (ko) 2023-05-04 2026-02-10 레볼루션 메디슨즈, 인크. Ras 관련 질환 또는 장애를 위한 병용 요법
WO2025006967A1 (en) 2023-06-30 2025-01-02 Bristol-Myers Squibb Company Kras inhibitors
CN121693329A (zh) * 2023-07-14 2026-03-17 锐新医药公司 治疗ras相关疾病或病症的方法
WO2025162395A1 (zh) * 2024-02-01 2025-08-07 山东先声生物制药有限公司 吲哚衍生物作为ras抑制剂及其应用
CN119431325A (zh) * 2024-10-31 2025-02-14 诚达药业股份有限公司 一种3-(1h-吡唑-1-基)氮杂环丁烷类化合物及其合成方法
WO2026124659A1 (zh) * 2024-12-13 2026-06-18 苏州泽璟生物制药股份有限公司 二羰基类抑制剂及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021091982A1 (en) * 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
WO2021091967A1 (en) * 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
WO2021091956A1 (en) * 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
WO2022060836A1 (en) * 2020-09-15 2022-03-24 Revolution Medicines, Inc. Indole derivatives as ras inhibitors in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL317393A (en) 2018-12-21 2025-02-01 Revolution Medicines Inc Compounds that participate in covalent bonds and their uses
DE102019122206B4 (de) 2019-08-19 2021-07-08 Webasto SE Dachmodul zur Bildung eines Fahrzeugdachs mit Umfeldsensor

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021091982A1 (en) * 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
WO2021091967A1 (en) * 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
WO2021091956A1 (en) * 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
WO2022060836A1 (en) * 2020-09-15 2022-03-24 Revolution Medicines, Inc. Indole derivatives as ras inhibitors in the treatment of cancer

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"Drugging the RAS(ON) Form of Diverse Oncogenic RAS Mutations", REVOLUTION MEDICINES [ONLINE], JPN6026026911, February 2021 (2021-02-01), ISSN: 0005897399 *
"Mechanisms of acquired resistance to KRAS G12C inhibition in cancer", ECANCER [ONLINE], JPN6026026907, 26 April 2021 (2021-04-26), ISSN: 0005897395 *
CANCER DISCOVERY, vol. 11, no. 8, JPN6026026909, 6 April 2021 (2021-04-06), pages 1913 - 1922, ISSN: 0005897397 *
CANCER RESEARCH, vol. Vol. 81,No. 13_Supplement, JPN6026026905, 1 July 2021 (2021-07-01), pages 1261, ISSN: 0005897393 *
CANCER RESEARCH, vol. Vol. 81,No. 13_Supplement, JPN6026026906, 1 July 2021 (2021-07-01), pages 002, ISSN: 0005897394 *
FUTURE MEDICINAL CHEMISTRY, vol. 12, no. 21, JPN6026026910, 2020, pages 1911 - 1923, ISSN: 0005897398 *
JOURNAL OF THORACIC ONCOLOGY, vol. 16, no. 8, JPN6026026908, 7 May 2021 (2021-05-07), pages 1321 - 1332, ISSN: 0005897396 *

Also Published As

Publication number Publication date
TW202313631A (zh) 2023-04-01
US20240277796A1 (en) 2024-08-22
CN117715658A (zh) 2024-03-15
CN118557730A (zh) 2024-08-30
AU2022281343A1 (en) 2023-11-30
MX2023013912A (es) 2024-02-12
IL308771A (en) 2024-01-01
WO2022251292A1 (en) 2022-12-01
CA3219533A1 (en) 2022-12-01
EP4346898A1 (en) 2024-04-10
KR20240026526A (ko) 2024-02-28

Similar Documents

Publication Publication Date Title
AU2022360536B2 (en) Ras inhibitors
JP7823816B2 (ja) Ras阻害剤
EP4054719B1 (en) Ras inhibitors
JP2024517847A (ja) Ras阻害剤
KR20240132492A (ko) Ras 억제제
KR20260027943A (ko) Ras 억제제
JP2024517845A (ja) がん治療のためのras阻害剤
KR20260005904A (ko) 매크로사이클릭 ras 억제제
KR20260007210A (ko) 매크로사이클릭 ras 억제제
WO2022251292A1 (en) Methods for inhibiting ras
JP2025521232A (ja) 大環状ras阻害剤
JP2022553859A (ja) Ras阻害剤
WO2025240847A1 (en) Ras inhibitors

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20250523

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250523

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260630